A meta-analytical approach for the treatment of in-stent restenosis.

نویسندگان

  • N Mercado
  • P W Serruys
چکیده

As noted repeatedly, the treatment of in-stent restenosis remains one of the most vexing shortcomings in interventional cardiology. Coronary restenosis is often manifested by symptom recurrence, which is translated into an increased rate of repeat revascularization. In this issue, Radke and colleagues report the results of a well-conducted meta-analysis with data gathered from published reports of 28 different studies. These studies included a total of 3012 patients with in-stent restenosis treated with six different modalities (stent-in-stent, rotational atherectomy, balloon angioplasty, laser angioplasty, directional atherectomy and vascular brachytherapy) and their clinical outcome at a follow-up of 9±64 months. Any major adverse cardiac event (MACE) as defined by death, myocardial infarction, and target lesion revascularization (TLR) occurred in 30% of the patients, irrespective of the type of device used. In 90% of these cases, this MACE rate was driven by the need for TLR as a result of restenosis. In the meta-regression analysis, post-procedural diameter stenosis (DS post) was significantly correlated with the MACE rate. The lower the DS post, the lower the MACE rate. After the adjustment of confounding factors (lesion length, pre-procedural diameter stenosis and diabetes), vascular brachytherapy was associated with a non-significant reduction of 16.9% in the probability of MACE, as compared to balloon angioplasty. The authors concluded that balloon angioplasty should be the preferred modality for the treatment of in-stent restenosis, particularly in focal lesions and that vascular brachytherapy should be considered in patients with diffuse in-stent restenosis. Several other issues deserve further credit and are worth mentioning in the light of recently published data. First, the authors are to be commended for addressing the difficult issue of how to treat in-stent restenosis, an area where little randomized controlled clinical data is available. However, if one looks specifically at intracoronary radiation for in-stent restenosis, the authors included only four studies in this analysis. These studies were two registries (Beta WRIST and Lausanne registry) and two randomized clinical trials (WRIST and GAMMA-1). In the mean time, several additional studies have emerged. A pooled analysis from the trials (Beta WRIST, START 30, START 40 and INHIBIT) showed a 33% relative reduction (RR) in MACE favouring brachytherapy. Similarly, a pooled analysis from the trials (SCRIPPS-2, WRIST, GAMMA-1, GAMMA-2, long WRIST, long WRIST high-dose and SVG WRIST) demonstrated a 36% RR and finally, when pooling the and trials, altogether, a 35% RR was exhibited. These data clearly support vascular brachytherapy as the preferred treatment of in-stent restenosis. Second, comparing individual treatment modalities (stent-in-stent, rotational atherectomy, laser angioplasty, directional atherectomy and vascular brachytherapy) to balloon angioplasty without taking into account the angiographic pattern of in-stent restenosis may be inappropriate. In this respect, the authors fall short in correlating the angiographic presentation (lesion length and * Corresponding author. Thoraxcenter, Clinical Epidemiology Unit, Department of Cardiology, Erasmus University Medical Center, Room H-554, 3015 Rotterdam, The Netherlands. Tel.: +31-10-4632893; fax: +31-10-4089484 E-mail address: [email protected] (N. Mercado). European Heart Journal (2003) 24, 217–218

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Overview of Intracoronary Brachytherapy for in-Stent Restenosis of a Drug-Eluting Stent

Percutaneous coronary intervention with stenting is considered recently as the most common procedure for the treatment of symptomatic coronary. The article reviewed 41 studies published during 1997-2019 on intracoronary brachytherapy for in-stent restenosis of a drug-eluting stent. Intracoronary radiation therapy was finally confirmed in the setting of in-stent restenosis using as adjunctive th...

متن کامل

Association of G22A variant of Adenosine Deaminase gene with coronary in-stent restenosis in coronary artery patients receiving drug-eluting stent

In-stent restenosis (ISR) is regarded as the main problem in the utilization of stents in the treatment of coronary artery atherosclerotic stenosis in percutaneous coronary intervention (PCI). This study investigated the possible role of the G22A variant of the Adenosine Deaminase gene (ADA) in the development of ISR. In this study, 91 patients who underwent PCI were divided into two groups of ...

متن کامل

نتایج بالینی پس از آنژیوپلاستی عروق کرونر، بروز حوادث بزرگ قلبی-عروقی و عوارض انواع استنت

Background: Cardiovascular diseases alone have become the leading cause of death worldwide. One of the treatment methods cardiovascular disease is angioplasty. This study aimed to investigate the clinical results after coronary artery angioplasty, based on the incidence of major cardiovascular events with emphasis on stent types. Methods: In this retrospective cross-sectional study, the preval...

متن کامل

عوامل پیشگویی‌کننده انسداد شاخه جانبی و عوارض زودرس آن به دنبال آنژیوپلاستی عروق کرونر

Background: Percutaneous Coronary Intervention (PCI) for bifurcated lesions is associated with a low rate of success and high rate of complications compared to such treatment of lesions of most other morphologies. Symptoms occurring at the time of procedure caused by PCI may require additional angiography with or without stenting through stent struts, which subsequently increases risks of reste...

متن کامل

Modeling and dose calculations of a pure beta emitting 32P coated stent for intracoronary brachytherapy by Monte Carlo code

Background: Recently, different investigators have studied the possibility of radiation therapy in restenosis prevention and have shown promising results. In this study a unique radioactive source for intra vascular brachytherapy (IVBT) was investigated. The two-dimensional dose distribution in water for a 32P IVBT stent has been calculated. The pure beta emitter source 32P has been co...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • European heart journal

دوره 24 3  شماره 

صفحات  -

تاریخ انتشار 2003